$1.21+0.12 (+11.01%)
Nano-X Imaging Ltd.
Nano-X Imaging Ltd. in the Healthcare sector is trading at $1.21 with a market capitalization of $119M. Wall Street consensus targets $6.53 (3 analysts), implying a +439.9% move over the next 12 months. The stock is currently near its 52-week low of $0.73, remaining 56.8% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.
| Metric (USD) | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|
| Total Revenue | $3.72M↑ | $3.45M↑ | $3.04M↑ | $2.81M↓ | $3.00M |
| Gross Profit | -$3.62M↓ | -$2.88M↑ | -$3.24M↓ | -$3.05M↓ | -$2.89M |
| Operating Income | -$17.88M↓ | -$14.23M↑ | -$14.49M↓ | -$14.09M↑ | -$14.97M |
| Net Income | -$33.37M↓ | -$13.68M↑ | -$14.72M↓ | -$13.24M↑ | -$14.06M |
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. It provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. The co...
Nano X Imaging Ltd (NNOX) reports increased revenues and strategic partnerships, but faces cash flow concerns and revised revenue targets.
BlackBerry also ranks highly before upcoming report
Need a quote from a Motley Fool analyst? Before we get started, I would like to remind everyone that management will be making statements during this call that include forward-looking statements regarding the company's financial results, research and development, manufacturing and commercialization activities, regulatory process and clinical activities, among other matters.
Nano-X Imaging Ltd. (NASDAQ:NNOX) earns a place on our list of the most popular AI penny stocks to buy. With distribution partnerships and deployment agreements beginning to translate into measurable commercial traction, Nano-X Imaging Ltd. (NASDAQ:NNOX) appears to be marking its entry into a scaled, partner-driven rollout phase. Nanox Impact Inc., the company’s subsidiary, penned […]
Analysts have trimmed Nano-X Imaging's fair value estimate from US$7.75 to US$6.65, a US$1.10 adjustment in the latest update. That change comes alongside a broader reset of key modeling inputs flagged in recent Street research, as analysts reassess how the story fits with their updated assumptions. As you read on, you will see how these shifts feed into the current narrative and what to watch if you want to keep up with future revisions. Analyst Price Targets don't always capture the full...